Pages

12/30/09

Marksans Pharma board approves to <b>sell</b> API business at Pune

... to USD 125 million, reports CNBC-TV18. There were pending buy orders of 2500 shares, with no sellers available. It was trading with volumes of 3480 shares.


See all stories on this topic

http://digg.com/u1Ite4

No comments:

Post a Comment